In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

The Philadelphia Citizen is recognizing CHOP doctors Alexis Thompson and Dr. Stephan Grupp with the 'Disruptors of the Year' ...

A new review and policy statement underscore the inaccuracy of sickle cell trait as a cause of death on autopsies.

Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen ...

Nearly a year after new sickle cell gene therapies were approved, CNBC's Bertha Coombs reports a small number of patients are starting to complete the months-long course of treatments, but the ...

The Philadelphia Citizen is recognizing CHOP doctors Alexis Thompson and Dr. Stephan Grupp with the Disruptors of the year ...

The Medical University of South Carolina Health has established the Rena N. Grant Sickle Cell Center to help treat those ...

A SYSTEMATIC review by the American Society of Hematology (ASH) has found no evidence to support sickle cell trait (SCT) as a cause of acute pain crises or sudden exertion-related death. This finding ...

The Medical University of South Carolina is expanding its access to state-supported Sickle Cell programs for “warriors,” or ...

It is believed around 1,700 people could be eligible for the treatment, while the NHS estimates around 50 people a year will ...

Scott Turner Department of Housing and Urban Development secretary, announced a new Department of Government Efficiency Task ...